XPH Stock Summary and Trading Ideas (State Street SPDR S&P Pharmaceuticals ETF | ARCA:XPH)

State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. The Index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the "Select Industry Indices"), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ("GICS").

What symbol and exchange does State Street SPDR S&P Pharmaceuticals ETF shares trade?

State Street SPDR S&P Pharmaceuticals ETF trades on the ARCA stock market under the symbol XPH.

What is State Street SPDR S&P Pharmaceuticals ETF stock price doing today?

As of September 11, 2026, XPH stock price declined to $67.51 with 424,691 million shares trading.

What is State Street SPDR S&P Pharmaceuticals ETF's Beta?

XPH has a beta of 0.70, meaning it tends to be less sensitive to market movements. XPH has a correlation of 0.19 to the broad based SPY ETF.

How much is State Street SPDR S&P Pharmaceuticals ETF worth?

XPH has a market cap of $587.36 million. This is considered a Small Cap stock.

What is the highest and lowest price State Street SPDR S&P Pharmaceuticals ETF traded in the last 3 year period?

In the last 3 years, XPH traded as high as $74.35 and as low as $34.67.

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a good investment?

XPH has outperformed the market in the last year with a return of +43.4%, while the SPY ETF gained +18.3%. In the last 3 month period, XPH beat the market returning +15.8%, while SPY returned +5.6%. However, in the most recent 2 weeks XPH has underperformed the stock market by returning -6.8%, while SPY returned -0.9%.

What are the support and resistance levels for State Street SPDR S&P Pharmaceuticals ETF (XPH)?

XPH support price is $67.09 and resistance is $68.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XPH shares will trade within this expected range on the day.